Hemodynamic and Clinical Outcomes of Milrinone Compared to Dobutamine in Cardiogenic Shock: A-Systematic Review and Meta-Analysis

Authors

  • William Bahagia Bhayangkara Hospital, Palangkaraya, Indonesia
  • Jimmy Oi Santoso Banten General Hospital, Indonesia.

DOI:

https://doi.org/10.30701/ijc.2027

Keywords:

Cardiogenic Shock, Dobutamine, Milrinone

Abstract

In “Hemodynamic and Clinical Outcomes of Milrinone Compared to Dobutamine in Cardiogenic Shock: A-Systematic Review and Meta-Analysis” (Indonesian Journal of Cardiology, 43(3), 108-15. https://doi.org/10.30701/ijc.1296), there is an error noted.

An error has been found in the PDF version of this article. The DOI printed in the PDF is incorrect. The correct DOI is https://doi.org/10.30701/ijc.1296. The error occurs only in the PDF; the DOI listed in the article metadata is already correct.

The publisher apologizes for any inconvenience caused by this error.

DOI of original article: https://doi.org/10.30701/ijc.1296

Downloads

Download data is not yet available.

References

Bahagia W. Hemodynamic and clinical outcomes of milrinone compared to dobutamine in cardiogenic shock: a systematic review and meta-analysis. Indones J Cardiol. 2022;43(3):108-15. doi:10.30701/ijc.1296

Downloads

Published

2025-12-16

How to Cite

Bahagia, W., & Santoso, J. O. (2025). Hemodynamic and Clinical Outcomes of Milrinone Compared to Dobutamine in Cardiogenic Shock: A-Systematic Review and Meta-Analysis. Indonesian Journal of Cardiology, 46(4), 226. https://doi.org/10.30701/ijc.2027